Abstract: Provided herein are binding polypeptides, such as binding peptides and antibodies, against a SARS CoV-2. The binding polypeptides relate to or are based on bovine antibodies, particularly those containing an ultralong CDR3. Also provided herein are methods of treating a virus infection, such as a coronavirus infection, by delivering to a subject in need a provided binding polypeptide.
Type:
Application
Filed:
May 11, 2022
Publication date:
August 8, 2024
Applicants:
Applied Biomedical Science Institute, Kansas State University Research Foundation